Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
FDA Inspection
•Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services•September 27, 2023

Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services – FDA Inspection, Sep 27, 2023

Record Details

This FDA Inspection record concerns Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services, with an inspection on September 27, 2023, issued by the New England District Office.

Company
Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
Inspection Date
September 27, 2023
Office
New England District Office
People
  • Erik W. Koester (FDA Associated Person)
  • Lane V. Christensen (Issuing Officer)
  • Samuel J Arsenault (Issuing Officer)
  • Sean R. Marcsisin (FDA Associated Person)
View Company Profile

ID · 30671712-4711-4ae1-ac69-3a9a86a3c601

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1218916
FDA center
Human Drugs
Outcome
Form 483 issued

FDA Citations

9
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.160(a)Deviations from laboratory control requirements
  3. 21 CFR 211.22(d)Procedures not in writing, fully followed
  4. 21 CFR 211.42(c)(10)(v)Cleaning System
  5. 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
  6. 21 CFR 211.58Buildings not maintained in good state of repair
  7. 21 CFR 211.63Equipment Design, Size and Location
  8. 21 CFR 211.67(b)Written procedures not established/followed
  9. 21 CFR 211.84(d)(3)Establish reliability of supplier's C of A

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services

8
DateClassificationOfficeProject area
June 10, 2026Not classifiedNew England District OfficeDrug Quality Assurance
May 24, 2024VAICenter for Drug Evaluation and ResearchNew Drug Evaluation
December 7, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 15, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 15, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
  • FDA Inspection 1321518 - 2026-06-10
  • FDA Inspection 1239754 - 2024-05-24
  • FDA Inspection 1074079 - 2018-12-07
  • FDA Inspection 1003136 - 2017-02-15
  • FDA Inspection 1002975 - 2017-02-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.